Bone-forming osteoblasts are differentiated from mesenchymal stem cells and dysregulation of this differentiation can lead to osteoporosis. Meanwhile, bone-resorbing osteoclasts are both differentiated and multinucleated from hematopoietic precursor cells of monocyte and/or macrophage lineage. Bone resorption inhibitors such as bisphosphonates and estrogen are used to treat osteoporosis. However, the adverse effects of the long-term use of these medicines are of concern, and so the development of new therapies to ameliorate osteoporosis is desirable. Therefore, in the present study, we screened 22 plant extracts and found that nine methanolic extracts of plants promote the differentiation of MC3T3-E1 cells to osteoblasts. These nine extracts were then evaluated for their inhibitory activity on osteoclast differentiation in RAW264.7 mouse macrophage cells. Of the nine extracts, Daucus carota, Vitis spp., Sasa veitchii, Euptelea polyandra, and Sesamum indicum exhibited proosteoblastic and anti-osteoclastic activity with low cytotoxicity, suggesting their potential effectiveness against osteoporosis.
Introduction
Osteoporosis is a condition characterized by a decrease in bone density and strength, resulting in fragile bones [1] . Normal bone is dependent on the balance of bone formation and resorption. Postmenopausal osteoporosis is a common bone disease in elderly women. Estrogen deficiency is known to increase bone turnover, leading to osteoclastic bone resorption [2] . For treatment against osteoporosis, bone resorption inhibitors, such as bisphosphonate, calcitonin, and estrogen, and bone formation promoters, such as parathyroid hormone, are used in the clinical setting. However, the adverse effects resulting from the long-term use of these medicines are of concern. For example, estrogen may increase the risk of breast and endometrial cancers [3] . Therefore, the development of new medicines against osteoporosis is desirable.
In the present study, we screened 22 plant extracts for the promotion of osteoblast differentiation and mineralization in the osteoblastic cell line MC3T3-E1 and the inhibition of osteoclast differentiation in RAW264.7 mouse macrophage cells. 
Materials and methods

Materials
Preparation of extracts
Dried samples were extracted with methanol under reflux for an hour three times to give the corresponding extract. These extracts were then evaporated to remove the organic solvent. The resulting extracts were stored at − 20 °C before use.
Cell culture and osteoblast differentiation
Osteoblastic MC3T3-E1 cells (mouse calvarial origin) were grown in α-minimal essential medium (α-MEM; Wako Pure Chemical Industries, Osaka, Japan) containing 10% fetal bovine serum (FBS; Thermo, Melbourne, Australia), 100 U/ mL penicillin, and 100 μg/mL streptomycin (Gibco BRL, New York, NY, USA) at 37 °C in a humidified atmosphere of 5% CO 2 in air.
For osteoblast differentiation, after the cells were grown to confluence, the culture medium was changed to an osteogenic medium containing 100 μg/mL ascorbic acid and 100 mM β-glycerophosphate (defined as differentiation medium) with or without samples. The medium was changed every 3 days. The differentiation of osteoblasts was evaluated based on staining alkaline phosphatase (ALP) activity. Cells were then rinsed and fixed with 4% paraformaldehyde. After treatment with ethanol/acetone (1:1) mixture, ALP activity in the cells was stained using 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium in 0.1 M Tris-buffered saline (pH 9.5). To quantify the ALP staining intensity, stained cells were dissolved in solvent containing 10% sodium dodecyl sulfate, 50% N,N-dimethylformamide, and 10% acetic acid, and the absorbance was measured at 540 nm using a microplate reader.
Cell viability
Cell proliferation and cytotoxicity were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. First, 1 mg/mL MTT solution was added to the cells and incubated for 2 h. After removal of the culture supernatants, formazan crystals were dissolved in isopropanol:dimethyl sulfoxide (1:1) solution. Absorbance was measured at 595 nm using a microplate reader.
Mineralization assay
Mineral depositions of osteoblasts were measured using Alizarin red S (Cosmo Bio, Tokyo, Japan) and von Kossa staining (Wako Pure Chemical Industries). At the end of culture, cells were fixed with 4% paraformaldehyde and stained with 40 mM Alizarin red S (pH 6.4) for 10 min. Fixed cells were also stained with von Kossa according to the manufacturer's instructions. Stained cells were then visualized using light microscopy and photographed.
Assay for osteoclast differentiation
Osteoclasts were differentiated from RAW264.7 mouse macrophage cells as described previously [4] . Briefly, cells were cultured with α-MEM containing 10% FBS on 96-well plates. For osteoclast differentiation, the cells were cultured in the presence of the receptor activator of NF-κB ligand (RANKL, 10 ng/mL; R & D Systems, Minneapolis, MN, USA) with or without test samples for 4 days. Next, the tartrate-resistant acid phosphatase (TRAP) activity of the medium was measured and TRAP staining was performed.
Measurement of TRAP activity and TRAP staining
The TRAP activity of osteoclasts was measured with culture media (30 μL) incubated for 20 min at 37 °C with 30 μL of 40 mM sodium acetate buffer (pH 5.5) containing l-ascorbic acid (10 mM), sodium tartrate dihydrate (40 mM), No. 4-nitrophenylphosphate Na (10 mM), Triton X-100 (0.2%), ethylenediaminetetraacetic acid (4 mM), and NaCl (40 mM). The reaction was terminated by the addition of 30 μL of NaOH (300 mM), and the absorbance was then measured at 405 nm. TRAP histochemical staining of the cells was performed using a leukocyte acid phosphatase kit (SigmaAldrich, St. Louis, MO, USA). Cultured cells were fixed with 100% methanol for 1 min at room temperature and airdried. TRAP staining was performed according to the manufacturer's instructions. TRAP-positive multinucleated (more than three nuclei) cells were photographed under inverted phase-contrast microscopy [5] .
Statistical analysis
The data are presented as mean ± standard deviation of at least three independent experiments. Statistical analysis was performed using Student's t test. In all analyses, P < 0.05 was taken to indicate statistical significance.
Results and discussion
In the present study, we screened 22 plant extracts for the promotion of osteoblast differentiation and mineralization in MC3T3-E1 cells. (Fig. 1) . However, these extracts did not enhance ALP activity at any concentration, including less than 5 μg/mL (data not shown were selected to further confirm the dose-dependent effect on the enhancement of ALP activity. All samples dosedependently increased ALP activity, reaching a maximum in the range of 25-100 μg/mL (Fig. 2a) . Odontoglossum
Harvengtense 'Tutu' (leaf) (No. 4) and E. polyandra (leaf) (No. 15) inhibited both ALP and MTT activity at a concentration of 100 μg/mL (Fig. 2b) . All other extracts except M. rubra (leaf) (No. 10) increased ALP activity without inducing cytotoxicity. Next, the selected plant extracts were evaluated for mineralization activities using Alizarin red S and von Kossa staining (Fig. 3) . Calcium deposition was not detected in undifferentiated MC3T3-E1 cells, whereas it was detected in the cells cultured in osteogenic medium for 2 weeks. Treatment with 50 μg/mL of these plant extracts except S. flavescens (root) further promoted calcium deposition as evaluated by Alizarin red S staining (Fig. 3) . Of these extracts, M. rubra 4 TRAP activity in RAW264.7 cells treated with selected plant extracts. a RAW264.7 cells were cultured in either undifferentiated media or RANKL-treated differentiated media without (control) or with selected plant extracts for 4 days. TRAP activity in the culture medium was measured (a) and MTT assay (b) was performed, as described in "Materials and methods". Each column represents the mean ± SD from three independent experiments. *P < 0.05 vs. control
